These structural distinctions likely underpin the divergent biological behaviors observed: STAT5B exhibits predominantly tumor-suppressive associations across epithelial cancers, while STAT5A demonstrates dual or even opposing effects in certain malignancies [5,19]. This evidence concerns the gene STAT5A and neoplasm.